The HTA body of the Tuscany Regional Healthcare issues two types of documents: HTA forms and motivational forms. With regional decree 13241 of July 4, 2022, Tuscany Regional Healthcare has published assessments of three medical devices in the cardiovascular area.
Below is the list of technologies that have been assessed:
- IntellaNav Stablepoint force-sensing ablation catheter for cardiac electrophysiological mapping with a catheter and, when used in conjunction with a radiofrequency generator, for cardiac ablation
- Recross OTW double lumen guide wire support catheter
- TauroPace, antimicrobial solution for bacterial contamination of implantable cardiac devices
See the regional decree and all assessments in Italian here.
This news is just one of about 300 market access news collected by our team in the subscription services "HTA Alerts" and "Reimbursement Alerts" every two weeks from more than 80 organizations. Access our paid subscription services to stay on top of all developments specifically for your products in Europe (reimbursement news) and globally (HTA news).
Not ready for a subscription service? Subscribe to our free-of-charge newsletter delivered every second week to get updates about key reimbursement developments in Europe (10-12 news every two weeks). First EU issues of both newsletters are available for download free-of-charge.